Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention.

about

Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI.

P2860

Q53835950-8838BFC7-96A9-4256-A038-C9B7F586BDD8

P2860

Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention.

Item

http://www.wikidata.org/entity/Q42748476

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical effect of ticagrelor ...... taneous coronary intervention.

@en

Clinical effect of ticagrelor ...... taneous coronary intervention.

@nl

type

Item

label

Clinical effect of ticagrelor ...... taneous coronary intervention.

@en

Clinical effect of ticagrelor ...... taneous coronary intervention.

@nl

prefLabel

Clinical effect of ticagrelor ...... taneous coronary intervention.

@en

Clinical effect of ticagrelor ...... taneous coronary intervention.

@nl

P1476

Clinical effect of ticagrelor ...... taneous coronary intervention.

@en

P2093

Ling Li

http://www.w3.org/2001/XMLSchema#string

Rui Yao

http://www.w3.org/2001/XMLSchema#string

Yanjiao Lu

http://www.w3.org/2001/XMLSchema#string

Yanshen Li

http://www.w3.org/2001/XMLSchema#string

Yanzhou Zhang

http://www.w3.org/2001/XMLSchema#string

Yapeng Li

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Resistance to antiplatelet drugs: current status and future research

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Prospective validation of the Thrombolysis in Myocardial Infarction Risk Score in the emergency department chest pain population

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention

Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

P304

2177-2184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2016.3224

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luo-Sha Zhao

P577

2016-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299653963

http://www.w3.org/2001/XMLSchema#string

P698

27284299

http://www.w3.org/2001/XMLSchema#string

P932

4887760

http://www.w3.org/2001/XMLSchema#string

Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention.

about

P2860

P2860

Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932